The Latest Cardiac and Vascular News
Radical Catheter Technologies Continues to Expand its Best-in-Class Patented Platform and Scale its Specialized Neurovascular Commercialization Team Radical Catheter Technologies Continues to Expand its Best-in-Class Patented Platform and Scale its Specialized Neurovascular Commercialization Team
New investor Sectoral Asset Management joins growth financing round to support acceleration of commercial growth April 7, 2026 WEST JORDAN, Utah— Route 92 Medical, Inc., a privately held medical technology company dedicated to improving outcomes for patients undergoing neurovascular intervention, today announced a $50 million growth financing. New investor Sectoral Asset Management joined […]
SUZHOU, China, March 18, 2026 /PRNewswire/ — Peijia Medical (9996.HK), a leading Chinese domestic company in the high-growth transcatheter valve therapeutics and neurovascular interventions markets, announced that its DCwire® Micro Guidewire has received 510(k) clearance from the U.S….
First clinical cases successfully completed; U.S. launch to be led by Kaneka’s Neurovascular division First clinical cases successfully completed; U.S. launch to be led by Kaneka’s Neurovascular division
SUMMIT RISE is expected to enroll up to 500 patients to evaluate the performance of Route 92 Medical’s neurovascular intervention device portfolio WEST JORDAN, Utah, March 9, 2026 – (GLOBE NEWSWIRE) — Route 92 Medical, Inc., a privately held medical technology company dedicated to improving outcomes for patients undergoing […]
Deal complements Medtronic’s Neurovascular portfolio, delivering simplicity and access when ‘time is brain’ GALWAY, Ireland, March 10, 2026 /PRNewswire/ — Medtronic today announced its entry into a definitive agreement to acquire Scientia Vascular, a company with critical, innovative…
SAN JOSE, Calif.–(BUSINESS WIRE)– #PT–VS3 Medical announced the first patients enrolled in first-in-human study evaluating VS3 Medical™ Stent System for symptomatic venous sinus stenosis.
Approval marks Harrison.ai’s second out of three Breakthrough designations to reach marketing authorization, and 9th FDA clearance covering a total of 13 radiological findings. SYDNEY & BOSTON–(BUSINESS WIRE)–Harrison.ai today announced FDA 510(k) clearance for acute infarct triage on non-contrast CT Brain. Acute infarct is one of the most difficult findings to […]
MINNEAPOLIS–(BUSINESS WIRE)–Children’s Minnesota is pleased to announce a $2.5 million, state-of-the-art biplane neuroangiography suite—the region’s only facility dedicated to pediatric neurointerventional procedures. This advanced imaging technology brings new treatment options for children with a variety of cerebrovascular diseases, further expanding Children’s Minnesota’s neurosurgical capabilities. “With this advanced biplane neuroangiography suite, we are raising the bar for children in
FDA-approved IDE trial to evaluate the safety and effectiveness of the nOCT™ Imaging System to provide quality images for diagnostic assessment during endovascular intracranial aneurysm treatment and follow-up FDA-approved IDE trial to evaluate the safety and effectiveness of the nOCT™ Imaging System to provide quality images for diagnostic assessment during endovascular intracranial aneurysm treatment and follow-up
